Hester Biosciences Limited (HESTERBIO.BO)
INR 2469.0
(1.32%)
INR 2469.0
(1.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.04 Billion | 2.66 Billion | 2.35 Billion | 2.14 Billion | 1.83 Billion | 1.78 Billion |
| Cost of Revenue | 1.77 Billion | 858.19 Million | 725.38 Million | 589.78 Million | 383.94 Million | 524.14 Million |
| Gross Profit | 1.27 Billion | 1.8 Billion | 1.62 Billion | 1.55 Billion | 1.44 Billion | 1.25 Billion |
| Operating Expenses | 908.84 Million | 1.38 Billion | 1.05 Billion | 965.94 Million | 988.69 Million | 631.68 Million |
| Selling, General and Administrative Expenses | 305.06 Million | 316.64 Million | 244.39 Million | 206.91 Million | 235.15 Million | 247.64 Million |
| Research and Development Expenses | - | - | - | 10.24 Million | 24.04 Million | 31.74 Million |
| Other Expenses | 603.78 Million | 8.06 Million | 5.56 Million | 10.52 Million | 9.15 Million | 8.58 Million |
| Cost and Expenses | 2.68 Billion | 2.24 Billion | 1.78 Billion | 1.55 Billion | 1.37 Billion | 1.15 Billion |
| Operating Income | 364.81 Million | 310.27 Million | 436.43 Million | 567.84 Million | 427.43 Million | 566.93 Million |
| Interest Expense | 94.29 Million | 51.49 Million | 25.76 Million | 60.62 Million | 63.89 Million | 53.04 Million |
| Income Tax Expense | 107.87 Million | 121.19 Million | 140.18 Million | 154.05 Million | 103.24 Million | 161.62 Million |
| Earnings before Tax | 273.44 Million | 401.54 Million | 535.02 Million | 501.03 Million | 413.26 Million | 568.56 Million |
| Net Income | 188.89 Million | 266.27 Million | 393.2 Million | 344.3 Million | 291.71 Million | 415.67 Million |
| Earnings Per Share Basic | 22.20 | 31.30 | 46.22 | 40.47 | 34.29 | 48.86 |
| Earnings Per Share Diluted | 22.20 | 31.30 | 46.22 | 40.47 | 34.29 | 48.86 |
| Weighted Average Shares Outstanding | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million |
| Gross Margin | 0.42 | 0.68 | 0.69 | 0.72 | 0.79 | 0.71 |
| EBIT Margin | 0.18 | 0.25 | 0.32 | 0.34 | 0.33 | 0.42 |
| Profit Margin | 0.06 | 0.10 | 0.17 | 0.16 | 0.16 | 0.23 |
| EBITDA | 539.47 Million | 619.2 Million | 731.93 Million | 700.21 Million | 617.68 Million | 752.45 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.19 | 0.26 | 0.23 | 0.32 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 836.92 Million | 822.67 Million | 792.55 Million | 3.04 Billion | 669.83 Million | 704.55 Million |
| Cost of Revenue | 245.17 Million | 435.7 Million | 413.85 Million | 1.77 Billion | 206.39 Million | 195.26 Million |
| Gross Profit | 591.75 Million | 386.97 Million | 378.7 Million | 1.27 Billion | 463.44 Million | 509.29 Million |
| Operating Expenses | 442.16 Million | 251.81 Million | 256.89 Million | 908.84 Million | 399.38 Million | 419.98 Million |
| Selling, General and Administrative Expenses | 241.2 Million | 251.81 Million | 256.89 Million | - | 206.08 Million | 212.65 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 442.16 Million | 12.25 Million | 41.45 Million | 106.38 Million | 9.9 Million | 43.58 Million |
| Cost and Expenses | 687.33 Million | 687.51 Million | 670.75 Million | 2.68 Billion | 605.77 Million | 615.24 Million |
| Operating Income | 149.59 Million | 135.16 Million | 121.8 Million | 364.81 Million | 64.06 Million | 89.31 Million |
| Interest Expense | 58.86 Million | 50.09 Million | 69.39 Million | 197.75 Million | 21.93 Million | 80.75 Million |
| Income Tax Expense | 34.77 Million | 31.06 Million | 34.72 Million | 107.87 Million | 23.91 Million | 27.22 Million |
| Earnings before Tax | 118.68 Million | 97.32 Million | 93.86 Million | 273.44 Million | 64.11 Million | 67.63 Million |
| Net Income | 81.99 Million | 63.36 Million | 49.5 Million | 188.89 Million | 39.84 Million | 40.86 Million |
| Earnings Per Share Basic | 9.64 | 7.45 | 7.52 | - | 4.68 | 4.80 |
| Earnings Per Share Diluted | 9.64 | 7.45 | 7.52 | - | 4.68 | 4.80 |
| Weighted Average Shares Outstanding | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million | 8.5 Million |
| Gross Margin | 0.71 | 0.47 | 0.48 | 0.42 | 0.69 | 0.72 |
| EBIT Margin | 0.26 | 0.21 | 0.20 | - | 0.18 | 0.27 |
| Profit Margin | 0.10 | 0.08 | 0.06 | 0.06 | 0.06 | 0.06 |
| EBITDA | 219.55 Million | 176.5 Million | 159.22 Million | - | 123.53 Million | 191.22 Million |
| Earnings Before Tax Margin | 0.18 | 0.16 | 0.15 | 0.12 | 0.10 | 0.13 |
BAYERCROP
000550
SILVERTUC
003040
VNO-PO
GMET